Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography

Archives of Virology

Volumn 158, Issue 5, 2013, Pages 933-942

  Huhti, L ^a   Tamminen, K ^a   Vesikari, T ^a   Blazevic, V ^a  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MIRIDAE; MUS; NOROVIRUS;

EID: 84876704712     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-012-1565-7     Document Type: Article

References (66)

1. Abe T, Hemmi H, Miyamoto H et al (2005) Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J Virol 79: 2847-2858. doi: 10. 1128/JVI. 79. 5. 2847-2858. 2005.
2. Abe T, Takahashi H, Hamazaki H et al (2003) Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J Immunol 171: 1133-1139.
3. Andreadis TG, Becnel JJ, White SE (2003) Infectivity and pathogenicity of a novel baculovirus, CuniNPV from Culex nigripalpus (Diptera: Culicidae) for thirteen species and four genera of mosquitoes. J Med Entomol 40: 512-517.
4. Atmar RL, Bernstein DI, Harro CD et al (2011) Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med 365: 2178-2187. doi: 10. 1056/NEJMoa1101245.
5. Ausar SF, Foubert TR, Hudson MH et al (2006) Conformational stability and disassembly of Norwalk virus-like particles. Effect of pH and temperature. J Biol Chem 281: 19478-19488. doi: 10. 1074/jbc. M603313200.
6. Ball JM, Graham DY, Opekun AR et al (1999) Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology 117: 40-48.
7. Ball JM, Hardy ME, Atmar RL et al (1998) Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J Virol 72: 1345-1353.
8. Becnel J, White S, Moser B et al (2001) Epizootiology and transmission of a newly discovered baculovirus from the mosquitoes Culex nigripalpus and C. quinquefasciatus. J Gen Virol 82: 275-282.
9. Bellier B, Dalba C, Clerc B et al (2006) DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant. Vaccine 24: 2643-2655. doi: 10. 1016/j. vaccine. 2005. 11. 034.
10. Blazevic V, Lappalainen S, Nurminen K et al (2011) Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis. Vaccine 29: 8126-8133. doi: 10. 1016/j. vaccine. 2011. 08. 026.
11. Buck CB, Thompson CD, Pang YY et al (2005) Maturation of papillomavirus capsids. J Virol 79: 2839-2846. doi: 10. 1128/JVI. 79. 5. 2839-2846. 2005.
12. Buesa J, Collado B, Lopez-Andujar P et al (2002) Molecular epidemiology of caliciviruses causing outbreaks and sporadic cases of acute gastroenteritis in Spain. J Clin Microbiol 40: 2854-2859.
13. Burova E, Ioffe E (2005) Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications. Gene Ther 12(Suppl 1): S5-17. doi: 10. 1038/sj. gt. 3302611.
14. Cannon JL, Lindesmith LC, Donaldson EF et al (2009) Herd immunity to GII. 4 noroviruses is supported by outbreak patient sera. J Virol 83: 5363-5374. doi: 10. 1128/JVI. 02518-08.
15. CBER g (2007) US Food and Drug Administration, Center for Biologics Evaluation and Research.
16. Crawford SE, Labbe M, Cohen J et al (1994) Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J Virol 68: 5945-5952.
17. Cruz PE, Maranga L, Carrondo MJ (2002) Integrated process optimization: lessons from retrovirus and virus-like particle production. J Biotechnol 99: 199-214.
18. Delchambre M, Gheysen D, Thines D et al (1989) The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J 8: 2653-2660.
19. Deml L, Speth C, Dierich MP et al (2005) Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses. Mol Immunol 42: 259-277. doi: 10. 1016/j. molimm. 2004. 06. 028.
20. El-Kamary SS, Pasetti MF, Mendelman PM et al (2010) Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J Infect Dis 202: 1649-1658. doi: 10. 1086/657087.
21. Glass RI, Noel J, Ando T et al (2000) The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics. J Infect Dis 181(Suppl 2): S254-261. doi: 10. 1086/315588.
22. Glass RI, Parashar UD, Estes MK (2009) Norovirus gastroenteritis. N Engl J Med 361: 1776-1785. doi: 10. 1056/NEJMra0804575.
23. Gronowski AM, Hilbert DM, Sheehan KC et al (1999) Baculovirus stimulates antiviral effects in mammalian cells. J Virol 73: 9944-9951.
24. Hansman GS, Natori K, Shirato-Horikoshi H et al (2006) Genetic and antigenic diversity among noroviruses. J Gen Virol 87: 909-919. doi: 10. 1099/vir. 0. 81532-0.
25. Harrington PR, Lindesmith L, Yount B et al (2002) Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol 76: 12335-12343.
26. Haynes JR, Dokken L, Wiley JA et al (2009) Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge. Vaccine 27: 530-541. doi: 10. 1016/j. vaccine. 2008. 11. 011.
27. Hervas-Stubbs S, Rueda P, Lopez L et al (2007) Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J Immunol 178: 2361-2369.
28. Huhti L, Blazevic V, Nurminen K et al (2010) A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles. Arch Virol 155: 1855-1858. doi: 10. 1007/s00705-010-0768-z.
29. Iritani N, Seto T, Hattori H et al (2007) Humoral immune responses against norovirus infections of children. J Med Virol 79: 1187-1193. doi: 10. 1002/jmv. 20897.
30. Iritani N, Seto Y, Kubo H et al (2003) Prevalence of Norwalk-like virus infections in cases of viral gastroenteritis among children in Osaka City, Japan. J Clin Microbiol 41: 1756-1759.
31. Jegerlehner A, Storni T, Lipowsky G et al (2002) Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation. Eur J Immunol 32: 3305-3314.
32. Jehle JA, Blissard GW, Bonning BC et al (2006) On the classification and nomenclature of baculoviruses: a proposal for revision. Arch Virol 151: 1257-1266. doi: 10. 1007/s00705-006-0763-6.
33. Jiang X, Wang M, Graham DY et al (1992) Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol 66: 6527-6532.
34. Kalbfuss B, Wolff M, Geisler L et al (2007) Direct capture of influenza A virus from cell culture supernatant with Sartobind anion-exchange membrane adsorbers. J Membr Sci 299: 251-260. doi: 10. 1016/j. memsci. 2007. 04. 048.
35. Kim HJ, Lim SJ, Kwag HL et al (2012) The choice of resin-bound ligand affects the structure and immunogenicity of column-purified human papillomavirus type 16 virus-like particles. PLoS ONE 7: e35893. doi: 10. 1371/journal. pone. 0035893.
36. Koho T, Mantyla T, Laurinmaki P et al (2012) Purification of norovirus-like particles (VLPs) by ion exchange chromatography. J Virol Methods 181: 6-11. doi: 10. 1016/j. jviromet. 2012. 01. 003.
37. Lenz P, Day PM, Pang YY et al (2001) Papillomavirus-like particles induce acute activation of dendritic cells. J Immunol 166: 5346-5355.
38. Lew JF, Valdesuso J, Vesikari T et al (1994) Detection of Norwalk virus or Norwalk-like virus infections in Finnish infants and young children. J Infect Dis 169: 1364-1367.
39. Lopman B, Vennema H, Kohli E et al (2004) Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet 363: 682-688. doi: 10. 1016/S0140-6736(04)15641-9.
40. Lu X, Chen Y, Bai B et al (2007) Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice. Immunology 122: 496-502. doi: 10. 1111/j. 1365-2567. 2007. 02676. x.
41. Makidon PE, Bielinska AU, Nigavekar SS et al (2008) Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine. PLoS ONE 3: e2954. doi: 10. 1371/journal. pone. 0002954.
42. Maranga L, Rueda P, Antonis AF et al (2002) Large scale production and downstream processing of a recombinant porcine parvovirus vaccine. Appl Microbiol Biotechnol 59: 45-50. doi: 10. 1007/s00253-002-0976-x.
43. Morenweiser R (2005) Downstream processing of viral vectors and vaccines. Gene Ther 12(Suppl 1): S103-110. doi: 10. 1038/sj. gt. 3302624.
44. Pang XL, Joensuu J, Vesikari T (1999) Human calicivirus-associated sporadic gastroenteritis in Finnish children less than two years of age followed prospectively during a rotavirus vaccine trial. Pediatr Infect Dis J 18: 420-426.
45. Park MA, Kim HJ, Kim HJ (2008) Optimum conditions for production and purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae. Protein Expr Purif 59: 175-181. doi: 10. 1016/j. pep. 2008. 01. 021.
46. Patel MM, Widdowson MA, Glass RI et al (2008) Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 14: 1224-1231.
47. Pattenden LK, Middelberg AP, Niebert M et al (2005) Towards the preparative and large-scale precision manufacture of virus-like particles. Trends Biotechnol 23: 523-529. doi: 10. 1016/j. tibtech. 2005. 07. 011.
48. Peixoto C, Sousa MF, Silva AC et al (2007) Downstream processing of triple layered rotavirus like particles. J Biotechnol 127: 452-461. doi: 10. 1016/j. jbiotec. 2006. 08. 002.
49. Pomfret TC, Gagnon JM Jr, Gilchrist AT (2011) Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics. J Clin Pharm Ther 36: 1-9. doi: 10. 1111/j. 1365-2710. 2009. 01150. x.
50. Prasad BV, Rothnagel R, Jiang X et al (1994) Three-dimensional structure of baculovirus-expressed Norwalk virus capsids. J Virol 68: 5117-5125.
51. Roldao A, Mellado MC, Castilho LR et al (2010) Virus-like particles in vaccine development. Expert Rev Vaccines 9: 1149-1176. doi: 10. 1586/erv. 10. 115.
52. Rueda P, Fominaya J, Langeveld JP et al (2000) Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles. Vaccine 19: 726-734.
53. Sailaja G, Skountzou I, Quan FS et al (2007) Human immunodeficiency virus-like particles activate multiple types of immune cells. Virology 362: 331-341. doi: 10. 1016/j. virol. 2006. 12. 014.
54. Saliki JT, Mizak B, Flore HP et al (1992) Canine parvovirus empty capsids produced by expression in a baculovirus vector: use in analysis of viral properties and immunization of dogs. J Gen Virol 73(Pt 2): 369-374.
55. Shi L, Sanyal G, Ni A et al (2005) Stabilization of human papillomavirus virus-like particles by non-ionic surfactants. J Pharm Sci 94: 1538-1551. doi: 10. 1002/jps. 20377.
56. Siebenga J, Kroneman A, Vennema H et al (2008) Food-borne viruses in Europe network report: the norovirus GII. 4 2006b (for US named Minerva-like, for Japan Kobe034-like, for UK V6) variant now dominant in early seasonal surveillance. Euro Surveill 13: 8009.
57. Smith GE, Summers MD, Fraser MJ (1983) Production of human beta interferon in insect cells infected with a baculovirus expression vector. Mol Cell Biol 3: 2156-2165.
58. Tamminen K, Huhti L, Koho T et al (2012) A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles. Immunology 135: 89-99. doi: 10. 1111/j. 1365-2567. 2011. 03516. x.
59. Velasquez LS, Shira S, Berta AN et al (2011) Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine. Vaccine 29: 5221-5231. doi: 10. 1016/j. vaccine. 2011. 05. 027.
60. Vicente T, Roldao A, Peixoto C et al (2011) Large-scale production and purification of VLP-based vaccines. J Invertebr Pathol 107(Suppl): S42-48. doi: 10. 1016/j. jip. 2011. 05. 004.
61. Vicente T, Sousa MFQ, Peixoto C et al (2008) Anion-exchange membrane chromatography for purification of rotavirus-like particles. J Membr Sci 311: 270-283. doi: 10. 1016/j. memsci. 2007. 12. 021.
62. Warfield KL, Bosio CM, Welcher BC et al (2003) Ebola virus-like particles protect from lethal Ebola virus infection. Proc Natl Acad Sci USA 100: 15889-15894. doi: 10. 1073/pnas. 2237038100.
63. Woo MK, An JM, Kim JD et al (2008) Expression and purification of human papillomavirus 18 L1 virus-like particle from saccharomyces cerevisiae. Arch Pharm Res 31: 205-209.
64. World Health Organization (2012) Document QAS/11. 413 Final. March 2012.
65. Wu C, Soh KY, Wang S (2007) Ion-exchange membrane chromatography method for rapid and efficient purification of recombinant baculovirus and baculovirus gp64 protein. Hum Gene Ther 18: 665-672. doi: 10. 1089/hum. 2007. 020.
66. Zheng DP, Ando T, Fankhauser RL et al (2006) Norovirus classification and proposed strain nomenclature. Virology 346: 312-323. doi: 10. 1016/j. virol. 2005. 11. 015.